PeraHealth has named Sloan Clardy senior vice president and chief growth officer. In this role, Clardy will lead sales operations and business development for PeraHealth, which provides real-time clinical surveillance software that helps nurses and doctors better monitor patients for subtle but serious health issues.
Clardy has two decades of experience managing high profile initiatives, leading teams and driving business growth. Most recently, he managed sales, marketing and business development for the Business Performance Group at Parallon, a subsidiary of HCA Holdings, Inc. (NYSE: HCA) that provides performance improvement services to 1,400 hospitals and 11,000 non-acute providers. Clardy also oversaw Central and Southeast U.S. business development and client management for MedAssets’ (NASDAQ: MDAS) revenue cycle division, partnering with over 500 provider organizations to improve operating margins and cash flow.
“Sloan has a proven record of delivering financial and operational improvement solutions for hospitals, health systems and physicians,” said PeraHealth CEO Stephanie Alexander. “His addition significantly enhances our commitment to implementing strategic business practices that promote sustained growth for PeraHealth and our clients.”
Clardy began his career at Ernst & Young directing clinical, operational and financial improvement efforts for major teaching hospitals, stand-alone urban and community facilities, and large integrated delivery systems. He holds a MBA from the Owen Graduate School of Management at Vanderbilt University, where he also earned a bachelor’s degree.
PeraHealth solutions provide hospitals with a full picture of patient condition, in the moment and trended over time. Powered by the Rothman Index, a disease-agnostic universal patient score for predicting mortality and readmission risk, PeraHealth software automatically pulls data from all major EHR systems. The data is translated into an index score and presented in color-coded graphs, allowing care teams to quickly visualize patient condition.
The Rothman Index is validated by 18 peer-reviewed publications, including a recent article detailing how its use by a nurse rapid response team was linked to a 30 percent mortality reduction.
Clinicians use PeraHealth solutions to:
- Remotely monitor patients across care settings
- Help determine when to discharge patients
- Prioritize patient bedside visits, nursing assignments
- Improve documentation accuracy, timeliness
- Optimize ICU bed use
- Recognize, communicate palliative care need
About PeraHealth
PeraHealth provides hospitals and health systems with a single solution for real-time clinical surveillance across all patient populations and care settings. Powered by the Rothman Index, a universal score for predicting patient readmission and mortality risk validated by 18 peer-reviewed publications, PeraHealth software pulls data from all major EHR systems with no added manual data entry for staff. The result is an earlier warning system trending patient condition over time, alerting clinicians to the potential for subtle patient deterioration to help optimize ICU use, hardwire rapid response teams and enhance palliative care services. Approximately 3.7 million clinicians, patients and families have benefited from PeraHealth solutions. For more information about Charlotte, N.C.-based PeraHealth, visit www.perahealth.com and @PeraHealth.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160106006093/en/
Contacts:
Alven Weil, 704-995-5607
aweil@perahealth.com
